Stay updated on INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.

Latest updates to the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry (v3.5.4) appears in the Study Record History, superseding the previous v3.5.3. This indicates an update to the record’s metadata rather than substantive changes to the study details.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, indicating a site UI/version maintenance change rather than an update to the trial record itself.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the history log.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history page.SummaryDifference0.1%

- Check103 days agoChange DetectedA new Revision: v3.4.2 has been added to the record history, replacing the previous v3.4.1. This is a minor UI/versioning update that does not affect clinical trial data or page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.